Published in Inflamm Bowel Dis on August 01, 2007
Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol (2012) 1.14
Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol (2014) 0.88
Guttate psoriasis induced by infliximab in a child with Crohn's disease. Inflamm Bowel Dis (2008) 0.80
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 1.81
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2002) 1.28
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology (2005) 1.23
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol (2008) 1.13
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis (2002) 1.12
Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis (2005) 1.03
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis (2005) 1.03
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med (2004) 1.02
Cytapheresis in inflammatory bowel diseases: current evidence and perspectives. Digestion (2008) 0.93
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance. Curr Med Chem (2007) 0.90
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study. Inflamm Bowel Dis (2011) 0.89
Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samples. Can J Gastroenterol (2006) 0.89
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol (2009) 0.88
Morphologically and immunohistochemically undifferentiated gastric neoplasia in a patient with multiple metastatic malignant melanomas: a case report. J Med Case Rep (2008) 0.86
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. World J Gastroenterol (2010) 0.84
Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2007) 0.84
Self-reported milk intolerance in irritable bowel syndrome: what should we believe? Clin Nutr (2004) 0.84
Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J Gastroenterol (2009) 0.84
Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis (2006) 0.83
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II. J Crohns Colitis (2009) 0.82
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis (2008) 0.82
GI distension in severe ulcerative colitis. Am J Gastroenterol (2002) 0.81
In favour of early surgery in Crohn's disease: a hypothesis to be tested. J Crohns Colitis (2010) 0.81
Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be? Clin Exp Gastroenterol (2013) 0.80
Biological agents for ulcerative colitis: hypes and hopes. Med Res Rev (2008) 0.80
Natalizumab in the treatment of Crohn's disease. Biologics (2008) 0.80
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms. Digestion (2015) 0.80
IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis (2009) 0.79
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol (2006) 0.79
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man. Dig Dis (2015) 0.79
Medical therapy for Crohn's disease: top-down or step-up? Dig Dis (2007) 0.79
The long journey of salicylates in ulcerative colitis: The past and the future. J Crohns Colitis (2009) 0.78
Hydrogen breath test for the diagnosis of lactose intolerance, is the routine sugar load the best one? World J Gastroenterol (2008) 0.78
Inflammatory bowel diseases: clinical update of practical guidelines. Nucl Med Commun (2005) 0.78
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. World J Gastroenterol (2011) 0.77
Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature. Int J Colorectal Dis (2006) 0.77
Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review. J Crohns Colitis (2011) 0.77
Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases. Dig Liver Dis (2013) 0.77
Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum. World J Gastroenterol (2006) 0.77
Frequency and Cause of Persistent Symptoms in Celiac Disease Patients on a Long-term Gluten-free Diet. J Clin Gastroenterol (2016) 0.77
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study. J Crohns Colitis (2010) 0.77
Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. Inflamm Bowel Dis (2007) 0.76
Clinical course of late-onset Crohn's disease. Inflamm Bowel Dis (2009) 0.75
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Inflamm Bowel Dis (2007) 0.75
Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease. Am J Gastroenterol (2004) 0.75
Oral beclomethasone: a review of its use in inflammatory bowel disease. Mini Rev Med Chem (2008) 0.75
The Role on Endoscopy in Alcohol-Related Diseases. Rev Recent Clin Trials (2016) 0.75
Microinvasive fimbrial fallopian tube carcinoma in a BRCA-2 mutation carrier. Int J Gynaecol Obstet (2008) 0.75
Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies. Inflamm Bowel Dis (2009) 0.75
Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy. J Clin Apher (2014) 0.75
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. Inflamm Bowel Dis (2008) 0.75
Perianal fistulas mimicking Crohn's disease in HIV-infected male patient. Am J Gastroenterol (2009) 0.75